Creative Medical Technology Holdings, Inc. (CELZ)

CELZ Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	5	6	5	16	16	1
Market Cap Growth	0.42%	18.77%	-66.73%	0.48%	2075.58%	-90.51%
Enterprise Value	-4	-4	-13	5	17	2
PE Ratio	-	-1.20	-0.53	0.84	-0.44	-0.09
PS Ratio	552.73	707.96	60.55	183.72	97.53	4.46
PB Ratio	0.54	0.62	0.34	1.58	-0.40	-0.09
P/FCF Ratio	-1.39	-0.79	-0.69	-7.28	-36.92	-0.61
P/OCF Ratio	-1.39	-0.79	-0.69	-7.28	-36.92	-0.61
EV/Sales Ratio	-213.91	-400.14	-146.96	61.67	101.80	10.40
EV/EBITDA Ratio	0.37	0.69	1.30	0.23	-0.48	-0.26
EV/EBIT Ratio	0.36	0.68	1.28	0.23	-0.48	-0.26
EV/FCF Ratio	0.38	0.45	1.67	-2.44	-38.54	-1.42
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-0.02	-0.13
Debt / EBITDA Ratio	0.00	0.00	0.00	0.00	-0.02	-0.16
Debt / FCF Ratio	0.00	0.00	0.00	-0.01	-1.84	-0.88
Quick Ratio	23.04	26.89	5.54	10.21	0.00	0.01
Current Ratio	23.54	27.66	5.64	10.22	0.00	0.01
Asset Turnover	0.00	0.00	0.01	0.02	0.32	0.37
Interest Coverage	-	-	-	5.49	-28.54	-3.48
Return on Equity (ROE)	-46.50%	-41.50%	-57.70%	1147.40%	290.80%	189.80%
Return on Assets (ROA)	-44.90%	-40.20%	-54.20%	480.20%	-7069.70%	-1888.30%
Return on Capital (ROIC)	-60.91%	-54.26%	-64.52%	-30.55%	2.86%	16.15%
Earnings Yield	-106.06%	-82.97%	-189.10%	119.17%	-226.41%	-1150.38%
FCF Yield	-102.18%	-125.99%	-145.34%	-13.74%	-2.71%	-164.49%
Buyback Yield / Dilution	-0.98%	-28.76%	-236.51%	-460.63%	-2700.68%	-164.92%
Total Shareholder Return	-0.98%	-28.76%	-236.51%	-460.63%	-2700.68%	-164.92%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).